Newsroom

Publication date (field_publication_date)
Grantee News · September 15, 2022
The use of rapid Covid tests has soared this year with the spread of omicron and free shipments organized by the Biden Administration. But in August the US Food and Drug Administration cautioned that people who get a negative result should still repeat the test a couple days later. That communication has led to a lot of confusion. Source: Bloomberg
Grantee News · September 9, 2022
NIH announced it will provide funding to diagnostic test manufacturers for the development of the next generation of COVID-19 tests, with a focus on improved accessibility. Source: LabPulse 
Grantee News · July 12, 2022
Over the past two years, the pulse oximeter has become a crucial tool for tracking the health of COVID-19 patients. The small device clips onto a finger and measures the amount of oxygen in a patient's blood. But a growing body of evidence shows the device can be inaccurate when measuring oxygen levels in people with dark skin tones. A study published in JAMA Internal Medicine only adds to this concern. Source: NPR
Grantee News · July 12, 2022
Patients with darker skin who received less accurate readings of their oxygen levels using pulse oximeters — the ubiquitous devices clamped on hospitalized patients’ fingers — also received less supplemental oxygen during ICU stays, according to a study published in JAMA Internal Medicine. Source: STAT
Grantee News · July 12, 2022
A flaw in a widely used medical device that measures oxygen levels causes critically ill Asians, Blacks and Hispanics to receive less supplemental oxygen to help them breathe than white patients, according to data from a large study published in JAMA Internal Medicine. Source: Reuters
Grantee News · June 2, 2022

After less than two years of data collection and processing, RSNA has successfully delivered over 30,000 de-identified imaging studies to the Medical Imaging and Data Resource Center (MIDRC) project, an open-access platform which publishes data to be used for research. MIDRC is funded by NIBIB. Source: RSNA News

Grantee News · April 20, 2022
Two recent studies supported by the National Institutes of Health Rapid Acceleration of Diagnostics (RADx) Tech program demonstrate how widespread distribution of COVID-19 at-home antigen tests can be used as an effective public health strategy to reduce the spread of the disease. Source: UMass Chan
Grantee News · April 20, 2022
Two years ago, Sangeeta Bhatia and Christopher Chen founded a biotech company that on Wednesday officially launched as Satellite Bio in Cambridge, Massachusetts. The company aims to translate the work of Bhatia, Chen and their cofounder Arnav Chhabra into "tissue therapeutics" — regenerative medicines built from bioengineered tissue structures, or "satellites," that can be implanted into patients. Source: BiopharmaDive
Grantee News · April 19, 2022
A new type of COVID-19 test is hitting the market, and could change how we detect the virus. MicroGEM, a Virginia-based molecular biology company with a Charlottesville office, is using its new saliva test to track COVID-19. Source: NBC TV12 Richmond, Virginia.